Amid heightened public concern, the cost of prescription drugs is a focus of attention by the Biden administration and lawmakers in Congress and state capitals. Proposed actions range from allowing Medicare to negotiate the prices of certain drugs to limiting some drug price increases to inflation and capping out of pocket costs for Medicare beneficiaries in Part D, among other initiatives. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
Featured Prescription Drugs Resources
Out-of-pocket spending on insulin among people with private insurance
This analysis of insurance claims data finds that Congressional proposals to set a $35 per month cap on what people pay out of pocket for insulin would provide financial relief to at least 1 out of 5 insulin users with different types of private health insurance.
Issue Brief See More
Related Prescription Drugs Resources
- Public Opinion on Prescription Drugs and Their Prices
- Insulin Costs and Coverage in Medicare Part D
- Prices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020
- Dec. 8 Event: Unpacking the Prescription Drug Provisions of the Build Back Better Act
- The Public Weighs In On Medicare Drug Negotiations
- Potential Savings for Medicare Part D Enrollees Under Proposals to Add a Hard Cap on Out-of-Pocket Spending
- Medicare Part B Drugs: Cost Implications for Beneficiaries in Traditional Medicare and Medicare Advantage
- 10 FAQs on Prescription Drug Importation
- Medicaid Outpatient Prescription Drug Trends During the COVID-19 Pandemic
- Prescription Drug Rebates, Explained
- Who is most likely to have high prescription drug costs?
- Latest News on Prescription Drugs from Kaiser Health News
How Do Prescription Drug Costs in the United States Compare to Other Countries?
This chart collection examines what we know about prescription drug spending and use in the U.S. and comparably large and wealthy countries, using data from the Organization for Economic Cooperation and Development (OECD).
Slideshow See More
Refine Results
- view as grid
- view as list
The President’s Fiscal Year 2003 Budget: An Overview of Health Programs
The President's Fiscal Year 2003 Budget: An Overview of Health ProgramsA new chartbook describes the government's overall budget situation and examines the health policies and programs proposed in the President's latest budget.Chartbook View a webcast of A Capitol Hill briefing on budgets and health care
Report Read More The Financing of Illinois’ Prescription Drug Demonstration Project
This policy brief describes the financing of Illinois' new Medicaid prescription drug waiver. Policy Brief Also see The New Medicaid and CHIP Waiver Initiatives
Issue Brief Read More Health News Index – September/October 2000
Health News Index September/October, 2000 The September/October 2000 edition of the Kaiser Family Foundation/HarvardSchool of Public Health, Health News Index includes questions about how closely the public is following and how well they understand major health stories covered in the news during September, including stories about presidential candidates Al Gore…
Poll Finding Read More National ADAP Monitoring Project: Annual Report, 2001
National ADAP Monitoring Project Report This report, the fifth in an annual series, provides an overview of the status of state-administered AIDS Drug Assistance Programs (ADAPs) and documents how these programs are responding to the changing fiscal, clinical and epidemiological dynamics of HIV/AIDS. ADAPs, authorized under Title II of the…
Report Read More Medicaid and Prescription Drugs
An updated fact sheet summarizing the latest statistics and trends regarding the role of Medicaid in providing prescription drug coverage.Fact Sheet
Fact Sheet Read More Prescription Drug Coverage for the Medicare Population
Diane Rowland, executive director of the Commission, testified to the Subcommittee on Health of the U.S. House Committee on Energy and Commerce about providing prescription drugs to seniors. Her testimony includes discussion of Medicaid's role in providing outpatient drug coverage.Testimony Chart Pack
Report Read More The Crunch Continues: Medicaid Spending, Coverage and Policy in the Midst of a Recession
This annual 50-state survey finds that number of people on Medicaid and state spending on the program are climbing sharply as a result of the recession, straining state budgets and pressuring officials to curb costs despite increased financial help from the federal government through the American Recovery and Reinvestment Act…
Event Read More Medicare Advantage 2010 Data Spotlight: Plan Availability and Premiums
This data spotlight examines changes in the availability and premiums of private Medicare Advantage options for Medicare beneficiaries in 2010 as the annual open enrollment period begins. While the number of plans available in 2010 declined somewhat from 2009, the analysis finds that Medicare beneficiaries on average have 33 Medicare…
Issue Brief Read More Toward Making Medicare Work for Low-Income Beneficiaries: A Baseline Comparison of the Part D Low-Income Subsidy and Medicare Savings Programs Eligibility and Enrollment Rules
Toward Making Medicare Work for Low-Income Beneficiaries: A Baseline Comparison of the Part D Low-Income Subsidy and Medicare Savings Programs Eligibility and Enrollment RulesThis report examines how the low-income provisions of the Medicare drug benefit interact with state-level assistance provided through the Medicare Savings Program.The Medicare drug benefit provides additional…
Report Read More Additional Findings from the National Surveys of Doctors and Pharmacists
Two Kaiser Family Foundation national surveys of doctors and pharmacists examine additional findings on their views and experiences on a wide range of health care issues. The topics covered in the surveys include views and experiences with medical errors and quality issues, use of health care information technology, prescription drug…
Poll Finding Read More